Short excerpt from a March 18, 2025 YouTube interview featuring Robert Whitfield MD describing the SHARP methodology for evaluating and treating suspected breast implant illness. Whitfield frames SHARP as a diagnostic-plus-detox approach applicable to surgical patients, emphasizes pre-surgical "tox test" screening (notably for mold toxins), and states that autoimmune-type illnesses often present after implants rather than before.
Chapters
I mean, somebody's just saying, like, I don't feel well. How do you determine that breast implant illness is what a woman has?
We created a methodology called Sharp, and it's really just to look at all that testing plus create a detoxification program for them. And it can be used for any type of surgery because, you know, anybody is exposed to multiple things daily, monthly, throughout their life, they're going to build up a certain amount of toxicity. Your body's going to be able to handle a certain amount of it. But, you know, the joke is, like, when the bucket's full, the bucket runs over. And that's how my patients are now. And it could be anything. They could get exposed to mold. They could have a traumatic event in the family. Somebody passes away.
You have a list that you run through before the surgery to, like, basically eliminate any possibility that it's not breast implant analysis. Like your checking for mold. You're checking. Is that what you're saying? This detoxification happens before the surgery?
Yeah. The tox test is actually. It looks at mold toxins. Mold is a big problem.
Huge.
It's not easy. And if you don't know what's going on and you continually get exposed, it's going to have significant impact on your health.
Are most people with breast implant illness, are they diagnosed with an autoimmune disease before and then chose to get breast implants anyway, or are the autoimmune diseases popping up after the breast implants?
Yeah, it's the latter. They're told they're developing some kind of autoimmune disease.
